Oxidation of apolipoprotein(a) inhibits kringle-associated lysine binding: The loss of intrinsic protein fluorescence suggests a role for tryptophan residues in the lysine binding site

Protein Science

Volumn 6, Issue 11, 1997, Pages 2324-2335

  Hermann, Anita ^a   Laws, William R ^a   Harpel, Peter C ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Apolipoprotein(a); Essential tryptophans; Kringles; Lipoprotein(a); Lysine binding site affinities; Oxidation; Protein fluorescence

Indexed keywords

APOLIPOPROTEIN A; LIPOPROTEIN A; LYSINE; PROTEIN; TRYPTOPHAN;

ARTICLE; BINDING AFFINITY; BINDING SITE; FLUORESCENCE; KRINGLE DOMAIN; LIPID OXIDATION; PRIORITY JOURNAL; PROTEIN BINDING;

EID: 0030711735     PISSN: 09618368     EISSN: None     Source Type: Journal    
DOI: 10.1002/pro.5560061105     Document Type: Article

References (51)

1. Armstrong VW, Harrach B, Robenek H, Helmhold M, Walli AK, Seidel D. 1990. Heterogeneity of human lipoprotein Lp(a): Cytochemical and biochemical studies on the interaction of two Lp(a) species with the LDL receptor. J Lipid Res 31:429-441.
2. Arni RK, Padmanabhan K, Padmanabhan KP, Wu TP, Tulinsky A. 1993. Structures of the noncovalent complexes of human and bovine prothrombin fragment 2 with human PPACK-thrombin. Biochemistry 32:4727-4737.
3. Berg K. 1963. A new serum type system in man: The Lp(a) system. Acta Pathol Microbiol Scand 59:369-382.
4. Boonmark NW, Schwartz K, Lou XJ, Pearle AJ, Rubin EM, Lawn RM. 1996. The role of apo(a) lysine binding site in atherosclerosis. Circulation 94:1-38.
5. Borth W, Chang V, Bishop P, Harpel PC. 1991. Lipoprotein(a) is a substrate for Factor XIIIa and tissue transglutaminase. J Biol Chem 266:18149-18153.
6. Bostom AG, Cupples LA, Jenner JL, Ordovas JM, Seman LJ, Wilson PWF, Schaefer EJ, Castelli WP. 1996. Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger. JAMA 276:544-548.
7. Cao G, Alessio HM, Cutler RG. 1993. Oxygen-radical absorbance capacity assay for antioxidants. Free Radical Biology & Medicine 14:303-311.
8. Davies KJA. 1987. Protein damage and degradation by oxygen radicals. I. General aspects. J Biol Chem 262:9895-9901.
9. Davies KJA, Delsignore ME, Lin SW. 1987. Protein damage and degradation by oxygen radicals. II. Modification of amino acids. J Biol Chem 262:9902-9907.
10. Dean RT, Hunt JV, Grant AJ, Yamamoto Y, Niki E. 1991. Free radical damage to proteins: The influence of the relative localization of radical generation, antioxidants, and target proteins. Free Radical Biology & Medicine 11:161-168.
11. Eisenthal R, Comish-Bowden A. 1974. The direct linear plot. A new graphical procedure for estimating enzyme kinetic parameters. Biochem J 139:115-720.
12. El-Saadani M, Esterbauer H, El-Sayed M, Goher M, Nassar AY, Jurgens G. 1989. A spectrophotometric assay for lipid peroxides in serum lipoproteins using a commercially available reagent. J Lipid Res 30:621-630.
13. Fless GM, Snyder ML. 1994. Polymorphic forms of Lp(a) with different structural and functional properties: Cold-induced self-association and binding to fibrin and lysine-Sepharose. Chem Phys Lipids 67/68:69-79.
14. Gaubatz JW, Chari MV, Nava ML, Guyton JR, Morrisett JD. 1987. Isolation and characterization of the two major apoproteins in human lipoprotein(a). J Lipid Res 28:69-19.
15. Gaubatz JW, Ghanem HI, Guevara J Jr, Nava ML, Patsch W, Morrisett JD. 1990. Polymorphic forms of human apolipoprotein(a): Inheritance and relationship of their molecular weights to plasma levels of lipoprotein(a). J Lipid Res 31:603-613.
16. 2-macroglobulin. Methods Enzymol 45:639-652.
17. Harpel PC, Chang VT, Borth W. 1992. Homocysteine and other sulfhydryl compounds enhance the binding of lipoprotein(a) to fibrin: A potential biochemical link between thrombosis, atherogenesis and sulfhydryl compound metabolism. Proc Natl Acad Sci USA 89:10193-10197.
18. Harpel PC, Gordon BR, Parker TS. 1989. Plasmin catalyzes binding of lipoprotein (a) to immobilized fibrinogen and fibrin. Proc Natl Acad Sci USA 86:3847-3851.
19. Harpel PC, Hermann A, Zhang X, Ostfeld I, Borth W. 1995. Lipoprotein(a), plasmin modulation, and atherogenesis. Throm Haemostas 74:382-386.
20. Hasselbacher CA, Waxman E, Galati LT, Contino PB, Ross JBA, Laws WR. 1991. Investigation of hydrogen bonding and proton transfer of aromatic alcohols in nonaqueous solvents by steady-state and time-resolved fluorescence. J Phys Chem 95:2995-3005.
21. Hervio L, Durlach V, Girard-Globa A, Angles-Cano E. 1995. Multiple binding with identical linkage: A mechanism that explains the effect of lipoprotein(a) on fibrinolysis. Biochemistry 34:13353-13358.
22. Hoover-Plow JL, Miles LA, Fless GM, Scanu AM, Plow EF. 1993. Comparison of the lysine binding functions of lipoprotein(a) and plasminogen. Biochemistry 32:13681-13687.
23. Ichinose A. 1992. Multiple members of the plasminogen-apolipoprotein(a) gene family associated with thrombosis. Biochemistry 31:3113-3118.
24. Klezovitch O, Edelstein C, Scanu AM. 1996. Evidence that the fibrinogen binding domain of apo(a) is outside the lysine binding site of kringle IV-10. J Clin Invest 98:185-191.
25. Klezovitch O, Scanu A. 1996. Lys and fibrinogen binding of wild-type (Trp 72) and mutant (Arg 72) human apo(a) kringle IV-10 expressed in E. coli and CHO cells. Arterioscler Thromb Vasc Biol 16:392-398.
26. Koschinsky ML, Tomlinson JE, Zioncheck TF, Schwartz K, Eaton DL, Lawn RM. 1991. Apolipoprotein(a): Expression and characterization of a recombinant form of the protein in mammalian cells. Biochemistry 30:5044-5051.
27. Leerink CB, Duif P, Gimpel JA, Kortlandt W, Bouma BN, van Rijn HJM. 1992. Lysine-binding heterogeneity of Lp(a): Consequences for fibrin binding and inhibition of plaminogen activation. Thromb Haemostas 68:185-188.
28. Loscalzo J, Weinfeld M, Fless GM, Scanu AM. 1990. Lipoprotein(a), fibrin binding, and plasminogen activation. Arteriosclerosis 10:240-245.
29. McCance SG, Menhart N, Castellino FJ. 1994. Amino acid residues of the kringle-4 and kringle-5 domains of human plasminogen that stabilize their interactions with ω-amino acid ligands. J Biol Chem 269:32405-32410.
30. McLean JW, Tomlinson JE, Kuang WJ, Eaton DL, Chen EY, Fless GM, Scanu AM, Lawn RM. 1987. cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature 330:132-137.
31. McMullen BA, Fujikawa K. 1985. Amino acid sequence of the heavy chain of human alpha-factor XIIa (activated Hageman factor). J Biol Chem 260:5328-5341.
32. Mikol V, LoGrasso PV, Boettcher BR. 1996. Crystal structures of apolipoprotein(a) kringle IV37 free and complexed with 6-aminohexanoic acid and with p-aminomethylbenzoic acid: Existence of novel and expected binding modes. J Mol Biol 256:751-761.
33. Miles LA, Fless GM, Levin EG, Scanu AM, Plow EF. 1989. A potential basis for the thrombotic risks associated with lipoprotein(a). Nature 339:301-303.
34. Miles LA, Plow EF. 1990. Lp(a): An interloper into the fibrinolytic system? Thromb Haemostas 65:331-335.
35. Nakamura T, Nishizawa T, Hagiya MEA, Seki T, Shimonishi M, Sugimura A, Tashiro K, Shimizu S. 1989. Molecular cloning and expression of human hepatocyte growth factor. Nature 342:440-443.
36. Naruszewicz M, Selinger E, Davignon J. 1992. Oxidative modification of lipoprotein(a) and the effect of β-carotene. Metabolism 41:1215-1224.
37. Niki E. 1990. Free radical initiators as source of water-or lipid-soluble peroxyl radicals. Methods Enzymol 186:100-108.
38. Pennica D, Holmes WE, Kohr WE, Harkins RN, Vehar GA, Ward CA, Bennett WF, Yelverton E, Seeburg PH, Heyneker HL, Goeddel DV, Collen D. 1983. Cloning and expression of human tissue-type plasminogen activator cDNA in E. coli. Nature (Lond) 301:214-221.
39. Rouy D, Loschinsky ML, Fleury V, Chapman J, Angles-Cano E. 1992. Apolipoprotein(a) and plasminogen interactions with fibrin: A study with recombinant apolipoprotein(a) and isolated plasminogen fragments. Biochemistry 31:6333-6339.
40. Scanu AM, Edelstein C. 1994. Apolipoprotein(a): Structural and functional consequences of mutations in kringle type 10 (or kringle 4-37). Clinical Genetics 46:42-45.
41. Scanu AM, Edelstein C. 1995. Kringle-dependent structural and functional polymorphism of apolipoprotein(a). Biochem Biophys Acta 1256:1-12.
42. Scanu AM, Miles LA, Fless GM, Pfaffinger D, Eisenbart J, Jackson E, HooverPlow JL, Brunck T, Plow EF. 1993. Rhesus monkey lipoprotein(a) binds to lysine sepharose and U937 monocytoid cells less efficiently than human lipoprotein(a). J Clin Invest 91:283-291.
43. Scanu AM, Pfaffinger D, Lee JC, Hinman J. 1994. A single point mutation (Trp72-Arg) in human apo(a) kringle 4-37 associated with a lysine binding defect in Lp(a). Biochem Biophys Acta 1227:41-45.
44. Shandholzer C, Saha N, Kark JD, Rees A, Jaross W, Dieplinger H, Hoppichler F, Boerwinkle E, Utermann G. 1992. Apo(a) isoforms predict risk for coronary heart disease. A study in six populations. Arteriosclerosis and Thrombosis 12:1214-1226.
45. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, Klenk DC. 1985. Measurement of protein using bicinchoninic acid. Anal Biochem 150:76-85.
46. Sottrup-Jensen L, Claeys H, Zajdel M, Petersen TE, Magnusson S. 1978. The primary structure of human plasminogen: Isolation ot two lysine-binding fragments and one "mini-" plasminogen (MW, 38,000) by elastase-catalyzed-specific limited proteolysis. In: Davidson JF, Rowan RM, Samama MM, Desnoyers PC, eds. Progress in chemical fibrinolysis and thrombolysis. New York: Raven Press. pp 191-209.
47. Stadtman ER. 1992. Protein oxidation and aging. Science 257:1220-1224.
48. Steffens GJ, Gunzler WA, Otting F, Frankus E, Flohe L. 1982. The complete amino acid sequence of low molecular mass urokinase trom human urine. Hoppe-Seyler's Z Physiol Chem 363:1043-1058.
49. Utermann G. 1989. The mysteries of lipoprotein(a). Science 246:904-910.
50. Witztum JL, Steinberg D. 1991. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest 88:1785-1792.
51. Wu TP, Padmanabhan K, Tulinsky A, Mulichak AM. 1991. The refined structure of the epsilon-aminocaproic acid complex of human plasminogen kringle 4. Biochemistry 30:10586-10594.